Mizuho Maintains Buy on Immunocore Hldgs, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Graig Suvannavejh has maintained a Buy rating on Immunocore Holdings (NASDAQ:IMCR) and increased the price target from $86 to $90.
March 05, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho has reaffirmed its Buy rating on Immunocore Holdings and raised the price target from $86 to $90.
The increase in price target by a reputable analyst like Graig Suvannavejh signals a strong confidence in Immunocore Holdings' future performance. This endorsement is likely to positively influence investor sentiment and could lead to a short-term increase in IMCR's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100